{"count": 7, "results": [{"_id": "35392559", "pmid": 35392559, "pmcid": "PMC8982084", "title": "The Function of Metformin in Aging-Related Musculoskeletal Disorders", "journal": "Front Pharmacol", "authors": ["Song Y", "Wu Z", "Zhao P"], "date": "2022-03-08T00:00:00Z", "doi": "10.3389/fphar.2022.865524", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "865524", "score": 50254.793, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Bone", "citations": {"NLM": "Song Y, Wu Z, Zhao P. The Function of Metformin in Aging-Related Musculoskeletal Disorders Front Pharmacol. 2022;13():865524. PMID: 35392559", "BibTeX": "@article{35392559, title={The Function of Metformin in Aging-Related Musculoskeletal Disorders}, author={Song Y and Wu Z and Zhao P}, journal={Front Pharmacol}, volume={13}, pages={865524}}"}}, {"_id": "32129462", "pmid": 32129462, "title": "Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.", "journal": "J Gerontol A Biol Sci Med Sci", "authors": ["Ahmadi S", "Razazan A", "Nagpal R", "Jain S", "Wang B", "Mishra SP", "Wang S", "Justice J", "Ding J", "McClain DA", "Kritchevsky SB", "Kitzman D", "Yadav H"], "date": "2020-06-18T00:00:00Z", "doi": "10.1093/gerona/glaa056", "meta_date_publication": "2020 Jun 18", "meta_volume": "75", "meta_issue": "7", "meta_pages": "e9-e21", "score": 50252.832, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Reduces Aging-Related Leaky @DISEASE_Winter_Shortland_Temple_syndrome @DISEASE_MESH:C536735 @@@Gut@@@ and Improves Cognitive @<m>DISEASE_Conversion_Disorder</m> @DISEASE_MESH:D003291 @@@Function@@@ by Beneficially Modulating @DISEASE_Winter_Shortland_Temple_syndrome @DISEASE_MESH:C536735 @@@Gut@@@ Microbiome/Goblet Cell/Mucin Axis.", "citations": {"NLM": "Ahmadi S, Razazan A, Nagpal R, Jain S, Wang B, Mishra SP, Wang S, Justice J, Ding J, McClain DA, Kritchevsky SB, Kitzman D, Yadav H. Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis. J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):e9-e21. PMID: 32129462", "BibTeX": "@article{32129462, title={Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.}, author={Ahmadi S and Razazan A and Nagpal R and Jain S and Wang B and Mishra SP and Wang S and Justice J and Ding J and McClain DA and Kritchevsky SB and Kitzman D and Yadav H}, journal={J Gerontol A Biol Sci Med Sci}, volume={75}, number={7}, pages={e9-e21}}"}}, {"_id": "35864523", "pmid": 35864523, "pmcid": "PMC9306160", "title": "Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study", "journal": "Diabetol Metab Syndr", "authors": ["Kolwelter J", "Striepe K", "Bosch A", "Kannenkeril D", "Ott C", "Schiffer M", "Schmieder RE"], "date": "2022-07-21T00:00:00Z", "doi": "10.1186/s13098-022-00874-1", "meta_date_publication": "2022 Jul 21", "meta_volume": "14", "meta_issue": "1", "meta_pages": "102", "score": 50228.06, "text_hl": "In each @SPECIES_9606 @@@patient@@@, we measured GFR (mGFR) by applying the constant infusion input clearance technique with sinistrin (Inutest; Fresenius, Linz, Austria) at baseline and after short-term (4-12 weeks) pharmacological intervention with cardioprotective agents (@CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@, @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@, @CHEMICAL_Linagliptin @CHEMICAL_MESH:D000069476 @@@linagliptin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@) that potentially lead to an alteration of renal @<m>DISEASE_Conversion_Disorder</m> @DISEASE_MESH:D003291 @@@function@@@. ", "citations": {"NLM": "Kolwelter J, Striepe K, Bosch A, Kannenkeril D, Ott C, Schiffer M, Schmieder RE. Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study Diabetol Metab Syndr. 2022 Jul 21;14(1):102. PMID: 35864523", "BibTeX": "@article{35864523, title={Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study}, author={Kolwelter J and Striepe K and Bosch A and Kannenkeril D and Ott C and Schiffer M and Schmieder RE}, journal={Diabetol Metab Syndr}, volume={14}, number={1}, pages={102}}"}}, {"_id": "31664444", "pmid": 31664444, "pmcid": "PMC6824222", "title": "Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy", "journal": "JAMA Netw Open", "authors": ["Hafner P", "Bonati U", "Klein A", "Rubino D", "Gocheva V", "Schmidt S", "Schroeder J", "Bernert G", "Laugel V", "Steinlin M", "Capone A", "Gloor M", "Bieri O", "Hemkens LG", "Speich B", "Zumbrunn T", "Gueven N", "Fischer D"], "date": "2019-10-02T00:00:00Z", "doi": "10.1001/jamanetworkopen.2019.14171", "meta_date_publication": "2019 Oct 2", "meta_volume": "2", "meta_issue": "10", "meta_pages": "e1914171", "score": 50068.805, "text_hl": "Children in the treatment group received 2500 mg of @CHEMICAL_Citrulline @CHEMICAL_MESH:D002956 @@@l-citrulline@@@ (via powder in sachets dissolved in @CHEMICAL_Water @CHEMICAL_MESH:D014867 @@@water@@@) and 250 mg of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (via @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin hydrochloride@@@ tablets). ", "citations": {"NLM": "Hafner P, Bonati U, Klein A, Rubino D, Gocheva V, Schmidt S, Schroeder J, Bernert G, Laugel V, Steinlin M, Capone A, Gloor M, Bieri O, Hemkens LG, Speich B, Zumbrunn T, Gueven N, Fischer D. Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy JAMA Netw Open. 2019 Oct 2;2(10):e1914171. PMID: 31664444", "BibTeX": "@article{31664444, title={Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy}, author={Hafner P and Bonati U and Klein A and Rubino D and Gocheva V and Schmidt S and Schroeder J and Bernert G and Laugel V and Steinlin M and Capone A and Gloor M and Bieri O and Hemkens LG and Speich B and Zumbrunn T and Gueven N and Fischer D}, journal={JAMA Netw Open}, volume={2}, number={10}, pages={e1914171}}"}}, {"_id": "27195294", "pmid": 27195294, "pmcid": "PMC4853928", "title": "The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study", "journal": "Biomed Res Int", "authors": ["Herath PM", "Cherbuin N", "Eramudugolla R", "Anstey KJ"], "date": "2016-01-01T00:00:00Z", "doi": "10.1155/2016/7208429", "meta_date_publication": "2016", "meta_volume": "2016", "meta_issue": "", "meta_pages": "7208429", "score": 50062.05, "text_hl": "3.3. Relation between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Cognitive Function", "citations": {"NLM": "Herath PM, Cherbuin N, Eramudugolla R, Anstey KJ. The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study Biomed Res Int. 2016;2016():7208429. PMID: 27195294", "BibTeX": "@article{27195294, title={The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study}, author={Herath PM and Cherbuin N and Eramudugolla R and Anstey KJ}, journal={Biomed Res Int}, volume={2016}, pages={7208429}}"}}, {"_id": "28536774", "pmid": 28536774, "title": "Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.", "journal": "Eur J Drug Metab Pharmacokinet", "authors": ["Rhee SJ", "Chung H", "Yi S", "Yu KS", "Chung JY"], "date": "2017-12-01T00:00:00Z", "doi": "10.1007/s13318-017-0418-x", "meta_date_publication": "2017 Dec", "meta_volume": "42", "meta_issue": "6", "meta_pages": "973-980", "score": 50047.58, "text_hl": "The predicted pharmacokinetic parameters, including maximum concentration, area under the time-concentration curve, and apparent oral clearance values, were within 1.5-fold of the observed data of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. In the simulation results, the systemic exposure of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was expected to be markedly increased not only with a decrease in renal @<m>DISEASE_Conversion_Disorder</m> @DISEASE_MESH:D003291 @@@function@@@ but also with severe @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@hepatic impairments@@@. ", "citations": {"NLM": "Rhee SJ, Chung H, Yi S, Yu KS, Chung JY. Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations. Eur J Drug Metab Pharmacokinet. 2017 Dec;42(6):973-980. PMID: 28536774", "BibTeX": "@article{28536774, title={Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.}, author={Rhee SJ and Chung H and Yi S and Yu KS and Chung JY}, journal={Eur J Drug Metab Pharmacokinet}, volume={42}, number={6}, pages={973-980}}"}}, {"_id": "27488051", "pmid": 27488051, "pmcid": "PMC4973063", "title": "Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial", "journal": "Trials", "authors": ["Hafner P", "Bonati U", "Rubino D", "Gocheva V", "Zumbrunn T", "Gueven N", "Fischer D"], "date": "2016-08-03T00:00:00Z", "doi": "10.1186/s13063-016-1503-1", "meta_date_publication": "2016 Aug 3", "meta_volume": "17", "meta_issue": "1", "meta_pages": "389", "score": 50040.312, "text_hl": "The aim of this study is to test if a 6-month treatment of a combination of @CHEMICAL_Citrulline @CHEMICAL_MESH:D002956 @@@l-citrulline@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is more effective than placebo in preventing @<m>DISEASE_Conversion_Disorder</m> @DISEASE_MESH:D003291 @@@loss of motor function@@@ and @DISEASE_Nerve_Degeneration @DISEASE_MESH:D009410 @@@muscle degeneration@@@ in @DISEASE_Muscular_Dystrophy_Duchenne @DISEASE_MESH:D020388 @@@DMD@@@. ", "citations": {"NLM": "Hafner P, Bonati U, Rubino D, Gocheva V, Zumbrunn T, Gueven N, Fischer D. Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial Trials. 2016 Aug 3;17(1):389. PMID: 27488051", "BibTeX": "@article{27488051, title={Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial}, author={Hafner P and Bonati U and Rubino D and Gocheva V and Zumbrunn T and Gueven N and Fischer D}, journal={Trials}, volume={17}, number={1}, pages={389}}"}}]}